Fund Holdings — Palo Alto Investors LP

Total Portfolio Value:
$769.87M
Total Bought:
$89.66M
Total Sold:
$154.12M
Net Transaction:
-$64.45M
Notable People:
Palo Alto Investors Gp Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)2,138,9631,940,993-197,970$143.31M$141.69M18.40%-$1.62M
Amicus Therapeutics Inc
COM
9,029,8438,145,311-884,532$89.58M$86.99M11.30%-$2.58M
BioMarin Pharmaceutical Inc.(BMRN)1,130,1671,090,056-40,111$93.05M$76.62M9.95%-$16.43M
United Therapeutics Corporation(UTHR)266,914183,246-83,668$85.03M$65.67M8.53%-$19.36M
Biogen Inc.(BIIB)289,050228,916-60,134$67.01M$44.37M5.76%-$22.63M
STAAR Surgical Company(STAA)1,381,6191,091,608-290,011$65.78M$40.55M5.27%-$25.23M
Acadia Pharmaceuticals Inc2,418,8412,523,956+105,115$39.31M$38.82M5.04%-$487.7K
Alnylam Pharmaceuticals, Inc.(ALNY)0140,681+140,681$0$38.69M5.03%+$38.69M
Prothena Corp PlcSHS
SHS
1,666,3781,737,964+71,586$34.39M$29.08M3.78%-$5.32M
Iovance Biotherapeutics, Inc.(IOVA)2,116,4033,041,685+925,282$16.97M$28.56M3.71%+$11.59M
Anaptysbio Inc803,641843,971+40,330$20.14M$28.27M3.67%+$8.13M
Sarepta Therapeutics, Inc.(SRPT)201,683210,258+8,575$31.87M$26.26M3.41%-$5.61M
Alkermes plcSHS(ALKS)495,592384,656-110,936$11.94M$10.77M1.40%-$1.18M
PTC Therapeutics, Inc.(PTCT)0264,469+264,469$0$9.81M1.27%+$9.81M
Align Technology Inc37,77237,7720$9.12M$9.61M1.25%+$486.9K
eHealth, Inc.(EHTH)2,350,1902,347,519-2,671$10.65M$9.58M1.24%-$1.07M
NovoCure Limited(NVCR)561,908593,540+31,632$9.63M$9.28M1.21%-$348.5K
Acelyrin Inc1,715,1801,792,895+77,715$7.56M$8.84M1.15%+$1.28M
Revance Therapeutics Inc5,257,0861,611,787-3,645,299$13.51M$8.37M1.09%-$5.15M
Syndax Pharmaceuticals, Inc.(SNDX)405,193405,1930$8.32M$7.80M1.01%-$518.6K
Sage Therapeutics Inc1,010,8331,010,8330$10.98M$7.30M0.95%-$3.68M
Gossamer Bio, Inc.(GOSS)6,277,0936,277,0930$5.66M$6.19M0.80%+$536.7K
Karyopharm Therapeutics Inc.(KPTI)5,102,1935,102,1930$4.43M$4.23M0.55%-$191.8K
Nevro Corp750,371750,3710$6.32M$4.19M0.54%-$2.12M
BioNTech SEADS(BNTX)025,206+25,206$0$2.99M0.39%+$2.99M
Verve Therapeutics Inc575,817575,8170$2.81M$2.79M0.36%-$23.0K
Edwards Lifesciences Corp039,473+39,473$0$2.60M0.34%+$2.60M
Mirum Pharmaceuticals, Inc.(MIRM)64,70064,7000$2.21M$2.52M0.33%+$311.2K
Relmada Therapeutics, Inc.(RLMD)732,400732,4000$2.20M$2.37M0.31%+$175.8K
Nuvation Bio Inc.CL A(NUVB)772,652772,6520$2.26M$1.77M0.23%-$486.8K
Taysha Gene Therapies, Inc.(TSHA)811,268811,2680$1.82M$1.63M0.21%-$186.6K
Travere Therapeutics, Inc.(TVTX)110,719110,7190$910.1K$1.55M0.20%+$638.8K
Stoke Therapeutics, Inc.(STOK)125,861125,8610$1.70M$1.55M0.20%-$153.6K
Bicycle Therapeutics Plc-AdrADS059,582+59,582$0$1.35M0.18%+$1.35M
Humana Inc.(HUM)3,9853,9850$1.49M$1.26M0.16%-$226.8K
Aldeyra Therapeutics, Inc.(ALDX)225,465225,4650$746.3K$1.22M0.16%+$469.0K
Yarrow Bioscience Inc(YARW)445,434445,4340$877.5K$837.4K0.11%-$40.1K
Elevation Oncology Inc1,800,1061,298,097-502,009$4.86M$778.7K0.10%-$4.08M
Instil Bio, Inc.(TIL)011,165+11,165$0$751.6K0.10%+$751.6K
Aclaris Therapeutics, Inc.(ACRS)569,832569,8320$626.8K$655.3K0.09%+$28.5K
Pyxis Oncology, Inc.(PYXS)0170,000+170,000$0$623.9K0.08%+$623.9K
Generation Bio Co150,475150,4750$424.3K$371.7K0.05%-$52.7K
Bluebird Bio Inc4,633,351604,260-4,029,091$4.56M$313.9K0.04%-$4.25M
UroGen Pharma Ltd.(URGN)24,50024,5000$411.1K$311.1K0.04%-$100.0K
Abeona Therapeutics Inc.(ABEO)012,865+12,865$0$81.3K0.01%+$81.3K
Alnylam Pharmaceuticals, Inc.(ALNY)183,1230-183,123$44.50M$0—-$44.50M
Cytokinetics, Incorporated(CYTK)111,7170-111,717$6.05M$0—-$6.05M
Page 1 of 1
Palo Alto Investors LP — 13F Holdings — Q3 2024 | TickerTrail